Pulmonary toxicity of carbon nanotubes and asbestos — Similarities and differences
Ken Donaldson(Royal College of Surgeons of Edinburgh), Craig A. Poland(The Queen's Medical Research Institute), Fiona Murphy(Centre for Inflammation Research), Marion MacFarlane(Medical Research Council), Tatyana Chernova(Medical Research Council)
Cited by 339
Related Papers
Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation
|The Journal of Experimental Medicine|2000|5.2k
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|2.9k
Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy
|Particle and Fibre Toxicology|2005|2.1k
Safe handling of nanotechnology
|Nature|2006|1.5k
Carbon Nanotubes: A Review of Their Properties in Relation to Pulmonary Toxicology and Workplace Safety
|Toxicological Sciences|2006|1.2k